Follow
Michael Buchert
Michael Buchert
Olivia Newton-John Cancer Research Institute
Verified email at onjcri.org.au - Homepage
Title
Cited by
Cited by
Year
Transcription factor AP-2 essential for cranial closure and craniofacial development
H Schorle, P Meier, M Buchert, R Jaenisch, PJ Mitchell
Nature 381 (6579), 235-238, 1996
7161996
STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
M Ernst, M Najdovska, D Grail, T Lundgren-May, M Buchert, H Tye, ...
The Journal of clinical investigation 118 (5), 1727-1738, 2008
4062008
The junction-associated protein AF-6 interacts and clusters with specific Eph receptor tyrosine kinases at specialized sites of cell–cell contact in the brain
M Buchert, S Schneider, V Meskenaite, MT Adams, E Canaani, T Baechi, ...
The Journal of cell biology 144 (2), 361-371, 1999
2511999
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
M Buchert, CJ Burns, M Ernst
Oncogene 35 (8), 939-951, 2016
2372016
Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk
MM Halford, J Armes, M Buchert, V Meskenaite, D Grail, ML Hibbs, ...
Nature genetics 25 (4), 414-418, 2000
2312000
The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
J Huynh, N Etemadi, F Hollande, M Ernst, M Buchert
Seminars in cancer biology 45, 13-22, 2017
1722017
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
MF Eissmann, C Dijkstra, A Jarnicki, T Phesse, J Brunnberg, AR Poh, ...
Nature communications 10 (1), 2735, 2019
1652019
Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells
C Darido, M Buchert, J Pannequin, P Bastide, H Zalzali, T Mantamadiotis, ...
Cancer research 68 (11), 4258-4268, 2008
1372008
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
S Thiem, TP Pierce, M Palmieri, TL Putoczki, M Buchert, A Preaudet, ...
The Journal of clinical investigation 123 (2), 2013
1302013
Mutagenesis and selection of PDZ domains that bind new protein targets
S Schneider, M Buchert, O Georgiev, B Catimel, M Halford, SA Stacker, ...
Nature biotechnology 17 (2), 170-175, 1999
1251999
DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma
S Boireau, M Buchert, MS Samuel, J Pannequin, JL Ryan, A Choquet, ...
Carcinogenesis 28 (2), 246-258, 2007
1072007
An in vitro assay of β-galactosidase from yeast
S Schneider, M Buchert, CM Hovens
Biotechniques 20 (6), 960-962, 1996
1061996
Genetic Dissection of Differential Signaling Threshold Requirements for the Wnt/β-Catenin Pathway In Vivo
M Buchert, D Athineos, HE Abud, ZD Burke, MC Faux, MS Samuel, ...
PLoS genetics 6 (1), e1000816, 2010
1052010
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
M Buchert, M Papin, C Bonnans, C Darido, WS Raye, V Garambois, ...
Proceedings of the National Academy of Sciences 107 (6), 2628-2633, 2010
922010
Functional interaction between the ZO-1-interacting transcription factor ZONAB/DbpA and the RNA processing factor symplekin
E Kavanagh, M Buchert, A Tsapara, A Choquet, MS Balda, F Hollande, ...
Journal of cell science 119 (24), 5098-5105, 2006
862006
Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt–β-catenin–mediated intestinal tumor growth and regeneration
TJ Phesse, M Buchert, E Stuart, DJ Flanagan, M Faux, S Afshar-Sterle, ...
Science signaling 7 (345), ra92-ra92, 2014
762014
Biochemical and structural insights into doublecortin-like kinase domain 1
O Patel, W Dai, M Mentzel, MDW Griffin, J Serindoux, Y Gay, S Fischer, ...
Structure 24 (9), 1550-1561, 2016
602016
Distinct requirements for the Sprouty domain for functional activity of Spred proteins
JAJ King, AFL Straffon, GM D'ABACO, CLC Poon, STT I, CM Smith, ...
Biochemical Journal 388 (2), 445-454, 2005
552005
β-Catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors
J Pannequin, N Delaunay, M Buchert, F Surrel, JF Bourgaux, J Ryan, ...
Gastroenterology 133 (5), 1554-1568, 2007
502007
MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors
A Sakthianandeswaren, MJ Parsons, D Mouradov, RN MacKinnon, ...
Cancer discovery 8 (8), 988-1005, 2018
492018
The system can't perform the operation now. Try again later.
Articles 1–20